← Browse by Condition
Medical Condition

mono

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06908096 Phase 1
Recruiting

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Enrollment
750 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →